Q4 2025 Earnings Call February 24, 2026 8:30 AM ESTCompany ParticipantsSpencer Kurn - Senior Vice President of ...
Iovance Biotherapeutics, Inc. demonstrates improved Q4 results, with $87M revenue and a 50% gross margin. Learn more about IOVA stock here.
With the benefit of attracting BHP Xplor into our organisation, we’re looking to longer-term exploration potential in the ...
Live Streaming on a mobile device only provides the primary video (usually instructor camera) and audio; but secondary video (usually slides) is not visible. On-demand recordings on mobile devices ...
Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results